- Home
- PKST vs SVRA Comparison
PKST vs SVRA Comparison
Compare PKST & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKST
- SVRA
- Stock Information
- Founded
- PKST 2008
- SVRA 2007
- Country
- PKST United States
- SVRA United States
- Employees
- PKST N/A
- SVRA N/A
- Industry
- PKST Real Estate Investment Trusts
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- PKST Real Estate
- SVRA Health Care
- Exchange
- PKST Nasdaq
- SVRA Nasdaq
- Market Cap
- PKST 474.0M
- SVRA 528.3M
- IPO Year
- PKST N/A
- SVRA N/A
- Fundamental
- Price
- PKST $13.29
- SVRA $2.27
- Analyst Decision
- PKST Buy
- SVRA Buy
- Analyst Count
- PKST 2
- SVRA 7
- Target Price
- PKST $15.50
- SVRA $7.57
- AVG Volume (30 Days)
- PKST 162.4K
- SVRA 994.7K
- Earning Date
- PKST 08-07-2025
- SVRA 08-11-2025
- Dividend Yield
- PKST 6.75%
- SVRA N/A
- EPS Growth
- PKST N/A
- SVRA N/A
- EPS
- PKST N/A
- SVRA N/A
- Revenue
- PKST $225,817,000.00
- SVRA N/A
- Revenue This Year
- PKST N/A
- SVRA N/A
- Revenue Next Year
- PKST N/A
- SVRA N/A
- P/E Ratio
- PKST N/A
- SVRA N/A
- Revenue Growth
- PKST 5.64
- SVRA N/A
- 52 Week Low
- PKST $9.89
- SVRA $1.89
- 52 Week High
- PKST $16.26
- SVRA $5.11
- Technical
- Relative Strength Index (RSI)
- PKST 60.50
- SVRA 42.79
- Support Level
- PKST $12.80
- SVRA $2.15
- Resistance Level
- PKST $13.55
- SVRA $2.30
- Average True Range (ATR)
- PKST 0.41
- SVRA 0.15
- MACD
- PKST -0.01
- SVRA 0.03
- Stochastic Oscillator
- PKST 63.67
- SVRA 42.86
About PKST Peakstone Realty Trust
Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.